| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5866558a008e47ea6ad319ebae64bb9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46401a458ff736056d7d5f909325b391
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a54029f58c72c02891abf14cd702daff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bf2927f731952a676003981211487bd1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a5c2999c558897d7f4425bdcb595b3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e5284e292f4df936c3c2dbd2cb5d56f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-44 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-00 |
| filingDate |
2008-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1d936eacadfcfa704e4e3c693ea18b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11477fb3508b3b44390e58f5506c2094
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c2ec05ab6309b148b643473d62f4c48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9079fe687aae9a8f6fb237d36ebd5d36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_083c208dd7c659ac3d6a1b7486d327e5 |
| publicationDate |
2012-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8323968-B2 |
| titleOfInvention |
Osteopontin for the prediction and treatment of cardiovascular diseases |
| abstract |
Osteopontin for the prediction and treatment of cardiovascular diseases The present invention relates to the use of endothelial progenitor cells (EPCs) and osteopontin for the treatment of cardiovascular diseases or complications. The invention also relates to the use of EPC osteopontin levels as a marker of the risk of the development of these cardiovascular complications. In particular, the invention provides compositions and methods based on osteopontin and the genes encoding osteopontin. |
| priorityDate |
2007-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |